Stomach Relief Liquid
NDC Package 55910-837-08
Package Information
Stomach Relief (bismuth subsalicylate) liquids is do not take more than 8 doses (120 mL) in 24 hoursuse until diarrhea stops but not more than 2 daysdrink plenty of clear fluids to help prevent dehydration caused by diarrheamL = millilitershake well before usingmeasure only with dosing cup provided. This formulation utilizes a liquid delivery system. Marketed by Dolgencorp, Inc. (dollar General & Rexall), this product is identified by NDC 55910-837 and is authorized under FDA application M008.
Identification & Billing
- RxCUI: 308763 - bismuth subsalicylate 1050 MG in 30 mL Oral Suspension
- RxCUI: 308763 - bismuth subsalicylate 35 MG/ML Oral Suspension
- RxCUI: 308763 - bismuth subsalicylate 1050 MG per 30 ML Oral Suspension
- RxCUI: 308763 - bismuth subsalicylate 525 MG per 15 ML Oral Suspension
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 55910 - Dolgencorp, Inc. (dollar General & Rexall)
- 55910-837 - Stomach Relief
- 55910-837-08 - 237 mL in 1 BOTTLE, PLASTIC
- 55910-837 - Stomach Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (55910-837). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 55910-837-08 identifies a specific commercial package of 237 ml in 1 bottle, plastic of Stomach Relief Ultra, a human over the counter drug labeled by Dolgencorp, Inc. (dollar General & Rexall). This liquid is formulated for oral use and contains bismuth subsalicylate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Dolgencorp, Inc. (dollar General & Rexall) on March 19, 2020. The current certification is valid through December 31, 2027.
How is this Dolgencorp, Inc. (dollar General & Rexall) product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 55910083708. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.